InvestorsObserver
×
News Home

This Pot Stock Has a Bearish Sentiment Score and is Rising: Should You Hold Tilray Inc (TLRY) Wednesday?

Wednesday, April 06, 2022 10:02 AM | InvestorsObserver Analysts

Mentioned in this article

This Pot Stock Has a Bearish Sentiment Score and is Rising: Should You Hold Tilray Inc (TLRY) Wednesday?

Tilray Inc is a player in the cannabis industry that is higher by 14.94% Wednesday. The market has been down on Tilray Inc (TLRY) stock recently. TLRY gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Tilray Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TLRY!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TLRY Stock Today?

Tilray Inc (TLRY) stock is trading at $8.08 as of 9:59 AM on Wednesday, Apr 6, a rise of $1.05, or 14.94% from the previous closing price of $7.03. The stock has traded between $7.50 and $8.13 so far today. Volume today is below average. So far 23,666,085 shares have traded compared to average volume of 43,069,026 shares.

More About Tilray Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Click Here to get the full Stock Report for Tilray Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App